Drug Profile


Alternative Names: RO 483657; RO 483657-000; Xubix

Latest Information Update: 20 Jul 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Genentech; Roche
  • Class Antiplatelets; Ischaemic heart disorder therapies
  • Mechanism of Action GPIIb-IIIa antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arterial thrombosis; Myocardial infarction; Unstable angina pectoris

Most Recent Events

  • 20 Jul 2000 Discontinued-III for Arterial thrombosis in World (PO)
  • 20 Jul 2000 Discontinued-III for Myocardial infarction in World (PO)
  • 20 Jul 2000 Discontinued-III for Unstable angina pectoris in World (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top